Startseite>>Signaling Pathways>> Microbiology & Virology>> HIV>>Celgosivir (MBI 3253)

Celgosivir (MBI 3253) (Synonyms: MBI 3253; MDL 28574; MX3253)

Katalog-Nr.GC32191

Celgosivir (MBI 3253) (MBI 3253; MDL 28574; MX3253) ist ein ⋱-Glucosidase-I-Inhibitor; hemmt das Bovine Virus Diarrhoe Virus (BVDV) mit einem IC50-Wert von 1,27 μM im In-vitro-Assay.

Products are for research use only. Not for human use. We do not sell to patients.

Celgosivir (MBI 3253) Chemische Struktur

Cas No.: 121104-96-9

Größe Preis Lagerbestand Menge
1mg
138,00 $
Auf Lager
5mg
321,00 $
Auf Lager
10mg
459,00 $
Auf Lager
25mg
920,00 $
Auf Lager
50mg
1.655,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Celgosivir (MBI 3253; MDL 28574; MX3253) is a novel α-glucosidase I inhibitor, an enzyme that plays a critical role in viral maturation by initiating the processing of the N-linked oligosaccharides of viral envelope glycoproteins.[1]

The quantity of THP-1 cells is 1 × 105 , cells were washed once with media and replaced with 500 μl with a serial 4-fold dilution starting from 200 μM or 50 μM.[3]

Celgosivir, stored at 100 mg/ml in PBS at 30 °C, were diluted with PBS before each dosing to obtain 1 mg/200 μl (50 mg/kg) or 0.2 mg/200 μl (10 mg/kg). [3]

[1]. Durantel D. Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection. Curr Opin Investig Drugs. 2009 Aug, 10(8):860-70. [2]. Whitby K et al. Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for thetreatment of hepatitis C. Antivir Chem Chemother, 2004 May, 15(3):141-51. [3]. Satoru Watanabe,Kitti Wing-Ki Chan et al. Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy. Antiviral Research, March 2016, Pages 10-19.

Bewertungen

Review for Celgosivir (MBI 3253)

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Celgosivir (MBI 3253)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.